date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.355144908277971.
The log-likelihood improved by 3.343.
Iteration 2 of at most 500:
Optimizing with step length 0.581248101443072.
The log-likelihood improved by 2.875.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 2.291.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1728.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       18     1256     1049      788      342      379      338 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     306      216      135       81       51       24        7        5 
degree16 degree17 
       2        1 
1 
disease_progression 
H-positive risk:  838 870 132 910 429 127 908 422 131 73 114 46 
H-negative risk:  870 838 908 910 422 429 127 132 114 131 46 73 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
2 
disease_progression 
H-positive risk:  839 871 133 905 434 126 907 421 132 74 113 45 
H-negative risk:  871 839 907 905 421 434 126 133 113 132 45 74 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
3 
disease_progression 
H-positive risk:  845 874 136 904 429 126 909 416 134 71 114 42 
H-negative risk:  874 845 909 904 416 429 126 136 114 134 42 71 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
4 
disease_progression 
H-positive risk:  853 878 136 903 423 126 908 408 135 71 116 43 
H-negative risk:  878 853 908 903 408 423 126 136 116 135 43 71 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
46 new agents 
5 
disease_progression 
H-positive risk:  860 878 137 899 416 129 912 404 135 70 115 45 
H-negative risk:  878 860 912 899 404 416 129 137 115 135 45 70 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
61 new agents 
6 
disease_progression 
H-positive risk:  861 881 138 895 414 129 912 404 135 68 117 46 
H-negative risk:  881 861 912 895 404 414 129 138 117 135 46 68 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
7 
disease_progression 
H-positive risk:  863 890 137 897 409 128 915 402 131 67 116 45 
H-negative risk:  890 863 915 897 402 409 128 137 116 131 45 67 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
44 new agents 
8 
disease_progression 
H-positive risk:  865 894 135 888 410 130 917 401 132 69 115 44 
H-negative risk:  894 865 917 888 401 410 130 135 115 132 44 69 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
53 new agents 
9 
disease_progression 
H-positive risk:  867 899 140 890 405 130 911 398 133 67 116 44 
H-negative risk:  899 867 911 890 398 405 130 140 116 133 44 67 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
10 
disease_progression 
H-positive risk:  872 903 141 883 410 133 907 391 135 67 115 43 
H-negative risk:  903 872 907 883 391 410 133 141 115 135 43 67 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
11 
disease_progression 
H-positive risk:  879 906 142 879 406 132 909 390 135 67 114 41 
H-negative risk:  906 879 909 879 390 406 132 142 114 135 41 67 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
12 
disease_progression 
H-positive risk:  886 914 142 877 401 133 898 391 135 66 116 41 
H-negative risk:  914 886 898 877 391 401 133 142 116 135 41 66 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 17 1 

clinical_engagement 
diagnosis 
demography 
72 new agents 
13 
disease_progression 
H-positive risk:  819 838 130 945 395 116 973 395 155 66 130 38 
H-negative risk:  838 819 973 945 395 395 116 130 130 155 38 66 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 18 4 

clinical_engagement 
diagnosis 
demography 
202 new agents 
14 
disease_progression 
H-positive risk:  848 861 134 914 391 118 938 414 151 64 125 42 
H-negative risk:  861 848 938 914 414 391 118 134 125 151 42 64 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 23 4 

clinical_engagement 
diagnosis 
demography 
53 new agents 
15 
disease_progression 
H-positive risk:  850 864 132 916 392 118 932 411 155 64 125 41 
H-negative risk:  864 850 932 916 411 392 118 132 125 155 41 64 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 24 4 

clinical_engagement 
diagnosis 
demography 
48 new agents 
16 
disease_progression 
H-positive risk:  853 868 134 908 393 119 936 405 150 66 126 42 
H-negative risk:  868 853 936 908 405 393 119 134 126 150 42 66 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 24 4 

clinical_engagement 
diagnosis 
demography 
57 new agents 
17 
disease_progression 
H-positive risk:  857 875 136 906 388 120 932 405 148 65 127 41 
H-negative risk:  875 857 932 906 405 388 120 136 127 148 41 65 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 28 4 

clinical_engagement 
diagnosis 
demography 
52 new agents 
18 
disease_progression 
H-positive risk:  854 880 135 904 387 119 936 408 146 64 126 41 
H-negative risk:  880 854 936 904 408 387 119 135 126 146 41 64 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 29 5 

clinical_engagement 
diagnosis 
demography 
62 new agents 
19 
disease_progression 
H-positive risk:  861 884 134 904 383 121 937 403 145 63 123 42 
H-negative risk:  884 861 937 904 403 383 121 134 123 145 42 63 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 28 6 

clinical_engagement 
diagnosis 
demography 
50 new agents 
20 
disease_progression 
H-positive risk:  862 885 135 910 382 122 930 406 144 61 121 42 
H-negative risk:  885 862 930 910 406 382 122 135 121 144 42 61 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 28 10 

clinical_engagement 
diagnosis 
demography 
62 new agents 
21 
disease_progression 
H-positive risk:  869 893 134 907 380 124 931 401 141 59 122 39 
H-negative risk:  893 869 931 907 401 380 124 134 122 141 39 59 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 32 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
22 
disease_progression 
H-positive risk:  877 903 135 902 375 123 931 395 141 59 120 39 
H-negative risk:  903 877 931 902 395 375 123 135 120 141 39 59 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 30 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
23 
disease_progression 
H-positive risk:  881 913 137 901 370 120 925 392 142 59 122 38 
H-negative risk:  913 881 925 901 392 370 120 137 122 142 38 59 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 32 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
24 
disease_progression 
H-positive risk:  884 917 137 897 366 120 932 393 139 58 119 38 
H-negative risk:  917 884 932 897 393 366 120 137 119 139 38 58 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 33 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
25 
disease_progression 
H-positive risk:  827 838 129 985 360 108 995 394 147 53 125 39 
H-negative risk:  838 827 995 985 394 360 108 129 125 147 39 53 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
160 new agents 
26 
disease_progression 
H-positive risk:  843 854 134 942 388 109 953 417 139 60 114 47 
H-negative risk:  854 843 953 942 417 388 109 134 114 139 47 60 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 37 14 

clinical_engagement 
diagnosis 
demography 
58 new agents 
27 
disease_progression 
H-positive risk:  850 863 132 932 391 109 949 413 137 58 116 50 
H-negative risk:  863 850 949 932 413 391 109 132 116 137 50 58 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 40 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
28 
disease_progression 
H-positive risk:  852 870 131 929 388 111 945 410 138 57 117 52 
H-negative risk:  870 852 945 929 410 388 111 131 117 138 52 57 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
29 
disease_progression 
H-positive risk:  857 875 134 931 380 109 938 411 139 55 119 52 
H-negative risk:  875 857 938 931 411 380 109 134 119 139 52 55 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
30 
disease_progression 
H-positive risk:  863 880 137 933 375 110 939 402 139 53 119 50 
H-negative risk:  880 863 939 933 402 375 110 137 119 139 50 53 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
31 
disease_progression 
H-positive risk:  870 881 138 929 378 110 935 398 138 53 120 50 
H-negative risk:  881 870 935 929 398 378 110 138 120 138 50 53 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  875 888 137 930 374 114 933 394 135 53 118 49 
H-negative risk:  888 875 933 930 394 374 114 137 118 135 49 53 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 43 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
33 
disease_progression 
H-positive risk:  871 889 138 928 374 113 935 400 137 52 116 47 
H-negative risk:  889 871 935 928 400 374 113 138 116 137 47 52 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 45 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
34 
disease_progression 
H-positive risk:  870 892 138 933 374 112 935 393 138 50 118 47 
H-negative risk:  892 870 935 933 393 374 112 138 118 138 47 50 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 48 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
35 
disease_progression 
H-positive risk:  871 894 139 923 380 114 935 390 140 50 118 46 
H-negative risk:  894 871 935 923 390 380 114 139 118 140 46 50 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 49 13 

clinical_engagement 
diagnosis 
demography 
57 new agents 
36 
disease_progression 
H-positive risk:  868 895 141 923 375 117 940 389 141 49 116 46 
H-negative risk:  895 868 940 923 389 375 117 141 116 141 46 49 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 49 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
37 
disease_progression 
H-positive risk:  805 840 130 983 369 111 1011 381 148 50 127 45 
H-negative risk:  840 805 1011 983 381 369 111 130 127 148 45 50 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
182 new agents 
38 
disease_progression 
H-positive risk:  832 860 132 952 382 115 966 399 143 47 126 46 
H-negative risk:  860 832 966 952 399 382 115 132 126 143 46 47 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 52 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
39 
disease_progression 
H-positive risk:  831 864 129 948 378 117 969 404 143 47 126 44 
H-negative risk:  864 831 969 948 404 378 117 129 126 143 44 47 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 52 13 

clinical_engagement 
diagnosis 
demography 
62 new agents 
40 
disease_progression 
H-positive risk:  840 866 131 945 374 119 965 403 143 48 122 44 
H-negative risk:  866 840 965 945 403 374 119 131 122 143 44 48 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
41 
disease_progression 
H-positive risk:  847 866 130 953 370 121 963 397 144 47 121 41 
H-negative risk:  866 847 963 953 397 370 121 130 121 144 41 47 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
42 
disease_progression 
H-positive risk:  847 872 129 955 378 122 958 387 143 47 121 41 
H-negative risk:  872 847 958 955 387 378 122 129 121 143 41 47 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
43 
disease_progression 
H-positive risk:  854 878 129 955 375 121 954 386 140 47 118 43 
H-negative risk:  878 854 954 955 386 375 121 129 118 140 43 47 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 58 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
44 
disease_progression 
H-positive risk:  856 880 130 943 381 122 955 383 142 46 121 41 
H-negative risk:  880 856 955 943 383 381 122 130 121 142 41 46 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
45 
disease_progression 
H-positive risk:  864 886 133 939 370 119 958 379 144 47 121 40 
H-negative risk:  886 864 958 939 379 370 119 133 121 144 40 47 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
46 
disease_progression 
H-positive risk:  869 892 129 931 366 119 965 377 143 47 122 40 
H-negative risk:  892 869 965 931 377 366 119 129 122 143 40 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
47 
disease_progression 
H-positive risk:  871 895 128 925 369 118 960 380 142 47 123 42 
H-negative risk:  895 871 960 925 380 369 118 128 123 142 42 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  873 894 130 935 359 119 958 379 140 46 122 45 
H-negative risk:  894 873 958 935 379 359 119 130 122 140 45 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
49 
disease_progression 
H-positive risk:  821 847 122 983 360 109 1008 378 151 46 130 45 
H-negative risk:  847 821 1008 983 378 360 109 122 130 151 45 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
131 new agents 
50 
disease_progression 
H-positive risk:  830 843 125 961 392 109 978 387 146 51 132 46 
H-negative risk:  843 830 978 961 387 392 109 125 132 146 46 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
51 
disease_progression 
H-positive risk:  832 861 125 957 390 107 970 387 144 51 130 46 
H-negative risk:  861 832 970 957 387 390 107 125 130 144 46 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
52 
disease_progression 
H-positive risk:  839 860 126 946 387 111 974 388 142 50 131 46 
H-negative risk:  860 839 974 946 388 387 111 126 131 142 46 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
53 
disease_progression 
H-positive risk:  846 867 128 940 383 110 970 386 143 50 134 43 
H-negative risk:  867 846 970 940 386 383 110 128 134 143 43 50 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
54 
disease_progression 
H-positive risk:  848 871 129 943 382 111 962 381 145 50 134 44 
H-negative risk:  871 848 962 943 381 382 111 129 134 145 44 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
55 
disease_progression 
H-positive risk:  850 872 130 943 381 111 957 381 146 50 135 44 
H-negative risk:  872 850 957 943 381 381 111 130 135 146 44 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
56 
disease_progression 
H-positive risk:  850 877 129 944 391 112 951 375 141 52 134 44 
H-negative risk:  877 850 951 944 375 391 112 129 134 141 44 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
57 
disease_progression 
H-positive risk:  859 874 131 949 387 110 945 375 142 50 133 45 
H-negative risk:  874 859 945 949 375 387 110 131 133 142 45 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
58 
disease_progression 
H-positive risk:  861 876 129 955 382 110 954 365 140 51 133 44 
H-negative risk:  876 861 954 955 365 382 110 129 133 140 44 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
59 
disease_progression 
H-positive risk:  859 876 129 956 377 110 959 364 139 51 134 46 
H-negative risk:  876 859 959 956 364 377 110 129 134 139 46 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
60 
disease_progression 
H-positive risk:  863 883 130 953 373 111 953 368 138 50 131 47 
H-negative risk:  883 863 953 953 368 373 111 130 131 138 47 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
61 
disease_progression 
H-positive risk:  803 825 122 1008 380 103 1005 373 147 50 139 45 
H-negative risk:  825 803 1005 1008 373 380 103 122 139 147 45 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
125 new agents 
62 
disease_progression 
H-positive risk:  814 827 121 993 396 106 988 383 147 44 134 47 
H-negative risk:  827 814 988 993 383 396 106 121 134 147 47 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
63 
disease_progression 
H-positive risk:  812 828 124 990 394 105 986 384 147 44 140 46 
H-negative risk:  828 812 986 990 384 394 105 124 140 147 46 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
64 
disease_progression 
H-positive risk:  813 838 123 989 392 104 981 383 148 45 140 44 
H-negative risk:  838 813 981 989 383 392 104 123 140 148 44 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
65 
disease_progression 
H-positive risk:  810 838 124 988 396 105 980 380 144 48 143 44 
H-negative risk:  838 810 980 988 380 396 105 124 143 144 44 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
66 
disease_progression 
H-positive risk:  821 836 123 991 397 106 970 374 145 49 144 44 
H-negative risk:  836 821 970 991 374 397 106 123 144 145 44 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
67 
disease_progression 
H-positive risk:  821 836 123 994 390 107 971 378 144 50 142 44 
H-negative risk:  836 821 971 994 378 390 107 123 142 144 44 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
68 
disease_progression 
H-positive risk:  817 837 123 998 390 108 971 379 141 53 140 43 
H-negative risk:  837 817 971 998 379 390 108 123 140 141 43 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
69 
disease_progression 
H-positive risk:  817 839 122 998 393 107 974 376 142 50 138 44 
H-negative risk:  839 817 974 998 376 393 107 122 138 142 44 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
70 
disease_progression 
H-positive risk:  821 844 123 995 392 110 967 375 141 51 135 46 
H-negative risk:  844 821 967 995 375 392 110 123 135 141 46 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
71 
disease_progression 
H-positive risk:  817 848 123 991 400 113 967 370 141 51 134 45 
H-negative risk:  848 817 967 991 370 400 113 123 134 141 45 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
72 
disease_progression 
H-positive risk:  817 845 125 997 392 114 970 369 140 51 137 43 
H-negative risk:  845 817 970 997 369 392 114 125 137 140 43 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
73 
disease_progression 
H-positive risk:  779 805 115 1035 391 111 1014 364 140 50 148 48 
H-negative risk:  805 779 1014 1035 364 391 111 115 148 140 48 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
74 
disease_progression 
H-positive risk:  782 809 119 1016 402 113 1000 374 137 52 140 56 
H-negative risk:  809 782 1000 1016 374 402 113 119 140 137 56 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
75 
disease_progression 
H-positive risk:  785 810 119 1017 411 112 994 371 136 51 137 57 
H-negative risk:  810 785 994 1017 371 411 112 119 137 136 57 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
76 
disease_progression 
H-positive risk:  795 805 119 1014 407 111 1002 368 135 51 135 58 
H-negative risk:  805 795 1002 1014 368 407 111 119 135 135 58 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
77 
disease_progression 
H-positive risk:  799 810 123 1012 402 115 998 365 134 50 135 57 
H-negative risk:  810 799 998 1012 365 402 115 123 135 134 57 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
78 
disease_progression 
H-positive risk:  799 810 123 1014 396 116 994 375 132 48 135 58 
H-negative risk:  810 799 994 1014 375 396 116 123 135 132 58 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  799 807 126 1019 387 117 1001 373 129 49 137 56 
H-negative risk:  807 799 1001 1019 373 387 117 126 137 129 56 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
51 new agents 
80 
disease_progression 
H-positive risk:  805 809 124 1015 388 116 1002 370 131 51 135 54 
H-negative risk:  809 805 1002 1015 370 388 116 124 135 131 54 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
81 
disease_progression 
H-positive risk:  806 811 124 1017 385 115 1001 370 134 49 136 52 
H-negative risk:  811 806 1001 1017 370 385 115 124 136 134 52 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
82 
disease_progression 
H-positive risk:  810 806 123 1023 388 118 996 368 134 47 136 51 
H-negative risk:  806 810 996 1023 368 388 118 123 136 134 51 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
83 
disease_progression 
H-positive risk:  810 808 121 1021 388 120 997 369 134 49 136 47 
H-negative risk:  808 810 997 1021 369 388 120 121 136 134 47 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
84 
disease_progression 
H-positive risk:  815 808 123 1017 392 119 1001 362 131 48 135 49 
H-negative risk:  808 815 1001 1017 362 392 119 123 135 131 49 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
85 
disease_progression 
H-positive risk:  760 767 110 1059 392 110 1062 355 142 48 148 47 
H-negative risk:  767 760 1062 1059 355 392 110 110 148 142 47 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
116 new agents 
86 
disease_progression 
H-positive risk:  767 762 111 1057 396 108 1044 371 145 42 150 47 
H-negative risk:  762 767 1044 1057 371 396 108 111 150 145 47 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
87 
disease_progression 
H-positive risk:  769 763 110 1058 400 110 1039 372 140 43 149 47 
H-negative risk:  763 769 1039 1058 372 400 110 110 149 140 47 43 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
88 
disease_progression 
H-positive risk:  766 767 112 1062 398 113 1041 369 143 42 142 45 
H-negative risk:  767 766 1041 1062 369 398 113 112 142 143 45 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
89 
disease_progression 
H-positive risk:  766 771 109 1064 396 114 1038 369 143 40 144 46 
H-negative risk:  771 766 1038 1064 369 396 114 109 144 143 46 40 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
90 
disease_progression 
H-positive risk:  762 782 113 1067 387 112 1029 376 142 40 143 47 
H-negative risk:  782 762 1029 1067 376 387 112 113 143 142 47 40 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
91 
disease_progression 
H-positive risk:  755 783 115 1068 392 113 1018 380 143 42 142 49 
H-negative risk:  783 755 1018 1068 380 392 113 115 142 143 49 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
92 
disease_progression 
H-positive risk:  763 788 115 1061 390 111 1019 379 145 40 143 46 
H-negative risk:  788 763 1019 1061 379 390 111 115 143 145 46 40 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
93 
disease_progression 
H-positive risk:  766 791 116 1063 390 112 1020 372 140 40 145 45 
H-negative risk:  791 766 1020 1063 372 390 112 116 145 140 45 40 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
94 
disease_progression 
H-positive risk:  761 797 118 1067 390 114 1016 369 139 40 144 45 
H-negative risk:  797 761 1016 1067 369 390 114 118 144 139 45 40 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
95 
disease_progression 
H-positive risk:  773 798 119 1070 394 116 1002 366 134 41 145 42 
H-negative risk:  798 773 1002 1070 366 394 116 119 145 134 42 41 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
96 
disease_progression 
H-positive risk:  775 801 118 1073 391 113 998 370 136 43 144 38 
H-negative risk:  801 775 998 1073 370 391 113 118 144 136 38 43 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
97 
disease_progression 
H-positive risk:  721 754 113 1121 384 103 1049 377 146 44 149 39 
H-negative risk:  754 721 1049 1121 377 384 103 113 149 146 39 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
98 
disease_progression 
H-positive risk:  705 747 114 1114 398 105 1038 395 143 48 149 44 
H-negative risk:  747 705 1038 1114 395 398 105 114 149 143 44 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
99 
disease_progression 
H-positive risk:  712 741 113 1108 411 106 1030 390 142 52 150 45 
H-negative risk:  741 712 1030 1108 390 411 106 113 150 142 45 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
100 
disease_progression 
H-positive risk:  715 738 111 1110 409 108 1031 386 144 52 148 48 
H-negative risk:  738 715 1031 1110 386 409 108 111 148 144 48 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
101 
disease_progression 
H-positive risk:  716 743 110 1116 402 107 1025 386 142 55 150 48 
H-negative risk:  743 716 1025 1116 386 402 107 110 150 142 48 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
102 
disease_progression 
H-positive risk:  720 736 111 1116 395 109 1028 388 146 55 150 46 
H-negative risk:  736 720 1028 1116 388 395 109 111 150 146 46 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
103 
disease_progression 
H-positive risk:  727 741 112 1115 395 107 1028 377 149 53 152 44 
H-negative risk:  741 727 1028 1115 377 395 107 112 152 149 44 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
104 
disease_progression 
H-positive risk:  728 755 113 1113 393 109 1027 366 148 50 154 44 
H-negative risk:  755 728 1027 1113 366 393 109 113 154 148 44 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
105 
disease_progression 
H-positive risk:  729 753 112 1110 395 109 1036 365 144 50 154 43 
H-negative risk:  753 729 1036 1110 365 395 109 112 154 144 43 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
106 
disease_progression 
H-positive risk:  730 757 113 1111 393 114 1024 367 141 52 152 46 
H-negative risk:  757 730 1024 1111 367 393 114 113 152 141 46 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
107 
disease_progression 
H-positive risk:  732 754 112 1119 388 115 1031 362 142 50 150 45 
H-negative risk:  754 732 1031 1119 362 388 115 112 150 142 45 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
108 
disease_progression 
H-positive risk:  734 763 112 1112 391 116 1021 365 145 51 148 42 
H-negative risk:  763 734 1021 1112 365 391 116 112 148 145 42 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
109 
disease_progression 
H-positive risk:  697 720 98 1142 398 109 1057 373 153 50 160 43 
H-negative risk:  720 697 1057 1142 373 398 109 98 160 153 43 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
110 
disease_progression 
H-positive risk:  686 723 99 1135 402 110 1052 384 143 59 163 44 
H-negative risk:  723 686 1052 1135 384 402 110 99 163 143 44 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
111 
disease_progression 
H-positive risk:  692 727 101 1135 398 111 1045 386 144 57 161 43 
H-negative risk:  727 692 1045 1135 386 398 111 101 161 144 43 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
112 
disease_progression 
H-positive risk:  695 731 102 1131 399 109 1044 381 147 60 156 45 
H-negative risk:  731 695 1044 1131 381 399 109 102 156 147 45 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  696 734 101 1136 388 109 1034 388 148 61 158 47 
H-negative risk:  734 696 1034 1136 388 388 109 101 158 148 47 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
114 
disease_progression 
H-positive risk:  699 728 103 1136 391 107 1034 389 148 60 156 49 
H-negative risk:  728 699 1034 1136 389 391 107 103 156 148 49 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
115 
disease_progression 
H-positive risk:  686 729 107 1139 390 108 1039 394 148 57 153 50 
H-negative risk:  729 686 1039 1139 394 390 108 107 153 148 50 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
116 
disease_progression 
H-positive risk:  680 722 105 1143 391 108 1046 398 150 54 153 50 
H-negative risk:  722 680 1046 1143 398 391 108 105 153 150 50 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
117 
disease_progression 
H-positive risk:  686 724 102 1136 386 112 1054 392 148 55 154 51 
H-negative risk:  724 686 1054 1136 392 386 112 102 154 148 51 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
118 
disease_progression 
H-positive risk:  683 728 104 1136 383 112 1053 388 154 54 154 51 
H-negative risk:  728 683 1053 1136 388 383 112 104 154 154 51 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
119 
disease_progression 
H-positive risk:  679 727 104 1144 377 112 1068 383 153 53 149 51 
H-negative risk:  727 679 1068 1144 383 377 112 104 149 153 51 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
120 
disease_progression 
H-positive risk:  677 722 105 1146 381 112 1074 378 153 52 148 52 
H-negative risk:  722 677 1074 1146 378 381 112 105 148 153 52 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
121 
disease_progression 
H-positive risk:  637 685 101 1185 376 108 1113 379 159 52 154 51 
H-negative risk:  685 637 1113 1185 379 376 108 101 154 159 51 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
122 
disease_progression 
H-positive risk:  632 690 102 1167 393 109 1096 392 153 58 152 56 
H-negative risk:  690 632 1096 1167 392 393 109 102 152 153 56 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
123 
disease_progression 
H-positive risk:  634 691 103 1175 389 107 1092 389 154 54 153 59 
H-negative risk:  691 634 1092 1175 389 389 107 103 153 154 59 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
124 
disease_progression 
H-positive risk:  642 692 104 1179 386 107 1086 387 156 53 152 56 
H-negative risk:  692 642 1086 1179 387 386 107 104 152 156 56 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
125 
disease_progression 
H-positive risk:  643 692 105 1179 384 110 1085 384 157 52 152 57 
H-negative risk:  692 643 1085 1179 384 384 110 105 152 157 57 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
126 
disease_progression 
H-positive risk:  637 682 104 1194 386 110 1090 377 158 52 155 55 
H-negative risk:  682 637 1090 1194 377 386 110 104 155 158 55 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
127 
disease_progression 
H-positive risk:  642 683 108 1192 390 108 1090 364 162 51 155 55 
H-negative risk:  683 642 1090 1192 364 390 108 108 155 162 55 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
128 
disease_progression 
H-positive risk:  645 680 109 1194 388 111 1096 363 157 49 157 51 
H-negative risk:  680 645 1096 1194 363 388 111 109 157 157 51 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
129 
disease_progression 
H-positive risk:  641 681 108 1201 396 112 1083 368 156 50 155 49 
H-negative risk:  681 641 1083 1201 368 396 112 108 155 156 49 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
130 
disease_progression 
H-positive risk:  637 674 107 1210 393 110 1087 365 161 53 153 50 
H-negative risk:  674 637 1087 1210 365 393 110 107 153 161 50 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
55 new agents 
131 
disease_progression 
H-positive risk:  637 672 105 1216 388 109 1083 373 162 53 152 50 
H-negative risk:  672 637 1083 1216 373 388 109 105 152 162 50 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
132 
disease_progression 
H-positive risk:  639 674 104 1210 392 109 1086 373 160 52 152 49 
H-negative risk:  674 639 1086 1210 373 392 109 104 152 160 49 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
133 
disease_progression 
H-positive risk:  639 669 101 1199 389 110 1094 383 161 52 154 49 
H-negative risk:  669 639 1094 1199 383 389 110 101 154 161 49 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
108 new agents 
134 
disease_progression 
H-positive risk:  652 657 98 1195 398 108 1068 403 159 57 156 49 
H-negative risk:  657 652 1068 1195 403 398 108 98 156 159 49 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
135 
disease_progression 
H-positive risk:  656 658 96 1194 401 108 1056 409 158 58 157 49 
H-negative risk:  658 656 1056 1194 409 401 108 96 157 158 49 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
50 new agents 
136 
disease_progression 
H-positive risk:  653 653 99 1190 401 109 1059 411 160 57 158 50 
H-negative risk:  653 653 1059 1190 411 401 109 99 158 160 50 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
137 
disease_progression 
H-positive risk:  652 654 97 1198 393 108 1062 411 160 55 159 51 
H-negative risk:  654 652 1062 1198 411 393 108 97 159 160 51 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
138 
disease_progression 
H-positive risk:  658 655 95 1206 391 106 1057 399 162 56 163 52 
H-negative risk:  655 658 1057 1206 399 391 106 95 163 162 52 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
93 new agents 
139 
disease_progression 
H-positive risk:  657 654 95 1213 388 105 1062 391 163 55 165 52 
H-negative risk:  654 657 1062 1213 391 388 105 95 165 163 52 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
140 
disease_progression 
H-positive risk:  657 654 97 1212 388 101 1061 399 161 54 164 52 
H-negative risk:  654 657 1061 1212 399 388 101 97 164 161 52 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
141 
disease_progression 
H-positive risk:  661 653 98 1209 382 101 1067 399 162 54 160 54 
H-negative risk:  653 661 1067 1209 399 382 101 98 160 162 54 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
142 
disease_progression 
H-positive risk:  664 661 99 1213 381 101 1059 394 159 51 161 57 
H-negative risk:  661 664 1059 1213 394 381 101 99 161 159 57 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
143 
disease_progression 
H-positive risk:  658 665 100 1216 386 100 1058 390 159 49 160 59 
H-negative risk:  665 658 1058 1216 390 386 100 100 160 159 59 49 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
144 
disease_progression 
H-positive risk:  661 667 97 1210 394 97 1056 391 161 49 160 57 
H-negative risk:  667 661 1056 1210 391 394 97 97 160 161 57 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
145 
disease_progression 
H-positive risk:  671 667 98 1207 390 99 1056 385 162 49 158 58 
H-negative risk:  667 671 1056 1207 385 390 99 98 158 162 58 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
146 
disease_progression 
H-positive risk:  666 679 102 1187 395 101 1051 391 164 52 154 58 
H-negative risk:  679 666 1051 1187 391 395 101 102 154 164 58 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
95 new agents 
147 
disease_progression 
H-positive risk:  670 680 103 1183 394 105 1048 389 164 52 156 56 
H-negative risk:  680 670 1048 1183 389 394 105 103 156 164 56 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
148 
disease_progression 
H-positive risk:  669 679 102 1183 396 107 1041 394 168 51 152 58 
H-negative risk:  679 669 1041 1183 394 396 107 102 152 168 58 51 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
149 
disease_progression 
H-positive risk:  660 681 99 1192 391 107 1050 389 167 51 153 60 
H-negative risk:  681 660 1050 1192 389 391 107 99 153 167 60 51 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
150 
disease_progression 
H-positive risk:  657 682 102 1193 388 104 1050 390 168 52 149 65 
H-negative risk:  682 657 1050 1193 390 388 104 102 149 168 65 52 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
151 
disease_progression 
H-positive risk:  667 685 103 1190 390 103 1040 389 166 52 151 64 
H-negative risk:  685 667 1040 1190 389 390 103 103 151 166 64 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
152 
disease_progression 
H-positive risk:  667 693 106 1185 392 102 1040 382 167 53 153 60 
H-negative risk:  693 667 1040 1185 382 392 102 106 153 167 60 53 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
153 
disease_progression 
H-positive risk:  677 694 106 1182 390 101 1036 382 169 51 153 59 
H-negative risk:  694 677 1036 1182 382 390 101 106 153 169 59 51 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 62 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
154 
disease_progression 
H-positive risk:  677 688 108 1182 390 98 1041 380 172 52 153 59 
H-negative risk:  688 677 1041 1182 380 390 98 108 153 172 59 52 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
155 
disease_progression 
H-positive risk:  671 685 109 1186 383 103 1055 374 169 52 153 60 
H-negative risk:  685 671 1055 1186 374 383 103 109 153 169 60 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
156 
disease_progression 
H-positive risk:  675 693 109 1181 386 101 1053 375 170 51 149 57 
H-negative risk:  693 675 1053 1181 375 386 101 109 149 170 57 51 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  676 686 110 1189 386 98 1055 372 168 52 149 59 
H-negative risk:  686 676 1055 1189 372 386 98 110 149 168 59 52 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
158 
disease_progression 
H-positive risk:  668 694 106 1175 405 101 1040 380 171 51 148 61 
H-negative risk:  694 668 1040 1175 380 405 101 106 148 171 61 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
159 
disease_progression 
H-positive risk:  667 691 109 1176 405 102 1045 381 170 49 147 58 
H-negative risk:  691 667 1045 1176 381 405 102 109 147 170 58 49 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
160 
disease_progression 
H-positive risk:  663 687 108 1170 414 105 1054 377 170 44 145 63 
H-negative risk:  687 663 1054 1170 377 414 105 108 145 170 63 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
161 
disease_progression 
H-positive risk:  660 699 108 1163 416 104 1058 376 172 39 143 62 
H-negative risk:  699 660 1058 1163 376 416 104 108 143 172 62 39 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
96 new agents 
162 
disease_progression 
H-positive risk:  664 701 108 1152 413 104 1062 378 171 39 146 62 
H-negative risk:  701 664 1062 1152 378 413 104 108 146 171 62 39 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
163 
disease_progression 
H-positive risk:  670 700 106 1156 412 106 1063 369 170 40 148 60 
H-negative risk:  700 670 1063 1156 369 412 106 106 148 170 60 40 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
164 
disease_progression 
H-positive risk:  673 693 105 1158 410 104 1062 378 170 41 146 60 
H-negative risk:  693 673 1062 1158 378 410 104 105 146 170 60 41 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  681 687 104 1160 413 106 1059 374 168 44 143 61 
H-negative risk:  687 681 1059 1160 374 413 106 104 143 168 61 44 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
166 
disease_progression 
H-positive risk:  683 685 104 1163 406 108 1051 378 171 47 144 60 
H-negative risk:  685 683 1051 1163 378 406 108 104 144 171 60 47 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
167 
disease_progression 
H-positive risk:  686 681 102 1168 407 108 1056 378 167 47 141 59 
H-negative risk:  681 686 1056 1168 378 407 108 102 141 167 59 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
168 
disease_progression 
H-positive risk:  686 677 104 1167 408 111 1058 381 164 48 137 59 
H-negative risk:  677 686 1058 1167 381 408 111 104 137 164 59 48 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
97 new agents 
169 
disease_progression 
H-positive risk:  688 668 106 1169 410 111 1063 379 163 49 136 58 
H-negative risk:  668 688 1063 1169 379 410 111 106 136 163 58 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
110 new agents 
170 
disease_progression 
H-positive risk:  700 668 105 1156 420 111 1059 371 162 54 135 59 
H-negative risk:  668 700 1059 1156 371 420 111 105 135 162 59 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
171 
disease_progression 
H-positive risk:  699 671 107 1145 421 114 1066 370 162 50 135 60 
H-negative risk:  671 699 1066 1145 370 421 114 107 135 162 60 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  696 673 107 1141 418 117 1069 379 158 46 134 62 
H-negative risk:  673 696 1069 1141 379 418 117 107 134 158 62 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
173 
disease_progression 
H-positive risk:  700 675 105 1145 409 120 1064 386 160 42 135 59 
H-negative risk:  675 700 1064 1145 386 409 120 105 135 160 59 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
174 
disease_progression 
H-positive risk:  701 675 103 1142 406 120 1070 386 161 44 138 54 
H-negative risk:  675 701 1070 1142 386 406 120 103 138 161 54 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
175 
disease_progression 
H-positive risk:  702 669 104 1148 397 122 1082 382 160 45 135 54 
H-negative risk:  669 702 1082 1148 382 397 122 104 135 160 54 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
176 
disease_progression 
H-positive risk:  704 665 106 1147 390 121 1087 380 164 46 137 53 
H-negative risk:  665 704 1087 1147 380 390 121 106 137 164 53 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
177 
disease_progression 
H-positive risk:  702 652 108 1153 388 122 1098 381 162 44 137 53 
H-negative risk:  652 702 1098 1153 381 388 122 108 137 162 53 44 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
178 
disease_progression 
H-positive risk:  704 648 104 1156 389 120 1108 371 157 47 142 54 
H-negative risk:  648 704 1108 1156 371 389 120 104 142 157 54 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
179 
disease_progression 
H-positive risk:  702 645 107 1149 387 123 1125 368 152 44 144 54 
H-negative risk:  645 702 1125 1149 368 387 123 107 144 152 54 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
180 
disease_progression 
H-positive risk:  698 647 109 1143 382 126 1130 375 152 42 144 52 
H-negative risk:  647 698 1130 1143 375 382 126 109 144 152 52 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
181 
disease_progression 
H-positive risk:  698 658 109 1132 382 126 1137 373 149 43 143 50 
H-negative risk:  658 698 1137 1132 373 382 126 109 143 149 50 43 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
94 new agents 
182 
disease_progression 
H-positive risk:  705 653 106 1126 390 127 1129 381 147 43 144 49 
H-negative risk:  653 705 1129 1126 381 390 127 106 144 147 49 43 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
183 
disease_progression 
H-positive risk:  703 657 107 1124 390 127 1125 390 147 43 138 49 
H-negative risk:  657 703 1125 1124 390 390 127 107 138 147 49 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
184 
disease_progression 
H-positive risk:  704 659 104 1125 395 126 1119 387 149 41 142 49 
H-negative risk:  659 704 1119 1125 387 395 126 104 142 149 49 41 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
185 
disease_progression 
H-positive risk:  709 662 105 1120 390 121 1124 380 156 44 140 49 
H-negative risk:  662 709 1124 1120 380 390 121 105 140 156 49 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
186 
disease_progression 
H-positive risk:  706 662 105 1133 384 124 1123 374 157 46 137 49 
H-negative risk:  662 706 1123 1133 374 384 124 105 137 157 49 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
63 new agents 
187 
disease_progression 
H-positive risk:  705 664 105 1130 387 126 1115 374 159 48 138 49 
H-negative risk:  664 705 1115 1130 374 387 126 105 138 159 49 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
188 
disease_progression 
H-positive risk:  712 674 101 1117 385 125 1117 376 158 47 139 49 
H-negative risk:  674 712 1117 1117 376 385 125 101 139 158 49 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
189 
disease_progression 
H-positive risk:  714 677 98 1115 387 127 1111 373 160 48 142 48 
H-negative risk:  677 714 1111 1115 373 387 127 98 142 160 48 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
190 
disease_progression 
H-positive risk:  712 675 97 1103 385 126 1120 378 159 51 143 51 
H-negative risk:  675 712 1120 1103 378 385 126 97 143 159 51 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
191 
disease_progression 
H-positive risk:  712 672 95 1106 390 122 1119 380 162 49 145 48 
H-negative risk:  672 712 1119 1106 380 390 122 95 145 162 48 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
192 
disease_progression 
H-positive risk:  711 669 94 1105 398 125 1114 383 161 47 142 51 
H-negative risk:  669 711 1114 1105 383 398 125 94 142 161 51 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
193 
disease_progression 
H-positive risk:  709 671 95 1104 393 123 1120 382 160 46 146 51 
H-negative risk:  671 709 1120 1104 382 393 123 95 146 160 51 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
194 
disease_progression 
H-positive risk:  709 676 93 1096 400 124 1119 381 162 45 145 50 
H-negative risk:  676 709 1119 1096 381 400 124 93 145 162 50 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
195 
disease_progression 
H-positive risk:  713 682 92 1088 402 124 1117 378 160 46 147 51 
H-negative risk:  682 713 1117 1088 378 402 124 92 147 160 51 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
196 
disease_progression 
H-positive risk:  717 677 92 1087 403 124 1118 379 157 49 145 52 
H-negative risk:  677 717 1118 1087 379 403 124 92 145 157 52 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
197 
disease_progression 
H-positive risk:  720 678 94 1098 400 120 1113 379 153 51 144 50 
H-negative risk:  678 720 1113 1098 379 400 120 94 144 153 50 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
198 
disease_progression 
H-positive risk:  721 677 92 1097 397 122 1107 383 154 51 147 52 
H-negative risk:  677 721 1107 1097 383 397 122 92 147 154 52 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
199 
disease_progression 
H-positive risk:  716 678 94 1090 408 119 1106 387 156 52 145 49 
H-negative risk:  678 716 1106 1090 387 408 119 94 145 156 49 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
200 
disease_progression 
H-positive risk:  706 683 94 1086 416 121 1106 388 154 54 143 49 
H-negative risk:  683 706 1106 1086 388 416 121 94 143 154 49 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
201 
disease_progression 
H-positive risk:  701 676 95 1088 415 124 1110 391 154 53 143 50 
H-negative risk:  676 701 1110 1088 391 415 124 95 143 154 50 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
202 
disease_progression 
H-positive risk:  704 676 96 1080 415 125 1106 397 149 56 146 50 
H-negative risk:  676 704 1106 1080 397 415 125 96 146 149 50 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
203 
disease_progression 
H-positive risk:  708 666 96 1085 415 127 1105 399 146 54 146 53 
H-negative risk:  666 708 1105 1085 399 415 127 96 146 146 53 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
204 
disease_progression 
H-positive risk:  699 664 98 1087 411 126 1114 400 148 55 144 54 
H-negative risk:  664 699 1114 1087 400 411 126 98 144 148 54 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
205 
disease_progression 
H-positive risk:  697 673 99 1082 412 126 1125 390 150 56 138 52 
H-negative risk:  673 697 1125 1082 390 412 126 99 138 150 52 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  698 680 100 1071 411 125 1122 395 148 58 135 57 
H-negative risk:  680 698 1122 1071 395 411 125 100 135 148 57 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
207 
disease_progression 
H-positive risk:  691 674 98 1080 411 127 1120 403 143 61 134 58 
H-negative risk:  674 691 1120 1080 403 411 127 98 134 143 58 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
208 
disease_progression 
H-positive risk:  688 680 99 1071 416 126 1113 402 147 62 136 60 
H-negative risk:  680 688 1113 1071 402 416 126 99 136 147 60 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  691 674 101 1074 417 126 1111 406 145 63 137 55 
H-negative risk:  674 691 1111 1074 406 417 126 101 137 145 55 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
210 
disease_progression 
H-positive risk:  687 673 99 1072 419 128 1111 407 148 62 140 54 
H-negative risk:  673 687 1111 1072 407 419 128 99 140 148 54 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
211 
disease_progression 
H-positive risk:  684 663 96 1077 420 127 1114 414 150 61 141 53 
H-negative risk:  663 684 1114 1077 414 420 127 96 141 150 53 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
212 
disease_progression 
H-positive risk:  685 659 93 1080 423 128 1111 413 147 61 148 52 
H-negative risk:  659 685 1111 1080 413 423 128 93 148 147 52 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
213 
disease_progression 
H-positive risk:  690 660 91 1080 417 128 1110 420 145 60 147 52 
H-negative risk:  660 690 1110 1080 420 417 128 91 147 145 52 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  679 667 93 1083 419 127 1119 417 141 59 145 51 
H-negative risk:  667 679 1119 1083 417 419 127 93 145 141 51 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
215 
disease_progression 
H-positive risk:  686 663 92 1083 420 124 1125 413 141 59 143 51 
H-negative risk:  663 686 1125 1083 413 420 124 92 143 141 51 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
216 
disease_progression 
H-positive risk:  683 669 91 1087 411 122 1133 406 142 59 143 54 
H-negative risk:  669 683 1133 1087 406 411 122 91 143 142 54 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
217 
disease_progression 
H-positive risk:  685 666 92 1080 415 122 1138 408 139 62 142 51 
H-negative risk:  666 685 1138 1080 408 415 122 92 142 139 51 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
218 
disease_progression 
H-positive risk:  678 666 97 1073 418 121 1137 415 139 63 144 49 
H-negative risk:  666 678 1137 1073 415 418 121 97 144 139 49 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
219 
disease_progression 
H-positive risk:  673 672 97 1066 421 120 1132 420 144 63 142 50 
H-negative risk:  672 673 1132 1066 420 421 120 97 142 144 50 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
220 
disease_progression 
H-positive risk:  675 672 96 1069 423 117 1134 415 144 64 141 50 
H-negative risk:  672 675 1134 1069 415 423 117 96 141 144 50 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
221 
disease_progression 
H-positive risk:  683 679 95 1058 423 116 1129 413 143 67 142 52 
H-negative risk:  679 683 1129 1058 413 423 116 95 142 143 52 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
222 
disease_progression 
H-positive risk:  682 680 96 1059 418 116 1132 413 141 67 145 51 
H-negative risk:  680 682 1132 1059 413 418 116 96 145 141 51 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
223 
disease_progression 
H-positive risk:  683 681 94 1056 423 113 1127 414 142 69 149 49 
H-negative risk:  681 683 1127 1056 414 423 113 94 149 142 49 69 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
224 
disease_progression 
H-positive risk:  671 687 92 1057 422 114 1140 409 140 67 151 50 
H-negative risk:  687 671 1140 1057 409 422 114 92 151 140 50 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
225 
disease_progression 
H-positive risk:  672 684 93 1062 411 113 1135 420 141 65 153 51 
H-negative risk:  684 672 1135 1062 420 411 113 93 153 141 51 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
226 
disease_progression 
H-positive risk:  680 682 92 1058 415 111 1135 417 144 65 151 50 
H-negative risk:  682 680 1135 1058 417 415 111 92 151 144 50 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
227 
disease_progression 
H-positive risk:  685 682 89 1058 419 110 1123 421 148 67 151 47 
H-negative risk:  682 685 1123 1058 421 419 110 89 151 148 47 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
228 
disease_progression 
H-positive risk:  692 675 89 1073 412 109 1113 418 149 68 154 48 
H-negative risk:  675 692 1113 1073 418 412 109 89 154 149 48 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
229 
disease_progression 
H-positive risk:  689 674 86 1073 422 107 1106 426 146 71 152 48 
H-negative risk:  674 689 1106 1073 426 422 107 86 152 146 48 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
230 
disease_progression 
H-positive risk:  698 676 86 1068 420 106 1105 428 146 68 150 49 
H-negative risk:  676 698 1105 1068 428 420 106 86 150 146 49 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
231 
disease_progression 
H-positive risk:  691 674 85 1066 430 104 1103 424 152 68 153 50 
H-negative risk:  674 691 1103 1066 424 430 104 85 153 152 50 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
232 
disease_progression 
H-positive risk:  686 673 86 1067 426 105 1110 427 154 66 152 48 
H-negative risk:  673 686 1110 1067 427 426 105 86 152 154 48 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
233 
disease_progression 
H-positive risk:  689 675 83 1061 429 104 1121 419 151 69 151 48 
H-negative risk:  675 689 1121 1061 419 429 104 83 151 151 48 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
234 
disease_progression 
H-positive risk:  686 677 85 1063 423 107 1117 422 150 69 153 48 
H-negative risk:  677 686 1117 1063 422 423 107 85 153 150 48 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
235 
disease_progression 
H-positive risk:  695 678 83 1059 416 110 1121 419 148 68 154 49 
H-negative risk:  678 695 1121 1059 419 416 110 83 154 148 49 68 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
236 
disease_progression 
H-positive risk:  691 674 85 1057 419 111 1128 420 147 68 151 49 
H-negative risk:  674 691 1128 1057 420 419 111 85 151 147 49 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
237 
disease_progression 
H-positive risk:  691 673 86 1055 421 112 1129 421 144 69 150 49 
H-negative risk:  673 691 1129 1055 421 421 112 86 150 144 49 69 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
238 
disease_progression 
H-positive risk:  694 670 87 1056 423 112 1129 417 146 70 147 49 
H-negative risk:  670 694 1129 1056 417 423 112 87 147 146 49 70 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
239 
disease_progression 
H-positive risk:  692 662 86 1059 422 113 1134 416 148 69 153 46 
H-negative risk:  662 692 1134 1059 416 422 113 86 153 148 46 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
240 
disease_progression 
H-positive risk:  692 668 86 1047 427 113 1137 418 145 70 154 43 
H-negative risk:  668 692 1137 1047 418 427 113 86 154 145 43 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  698 676 84 1041 433 110 1119 428 146 71 151 43 
H-negative risk:  676 698 1119 1041 428 433 110 84 151 146 43 71 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
242 
disease_progression 
H-positive risk:  697 671 83 1037 432 111 1130 426 146 70 154 43 
H-negative risk:  671 697 1130 1037 426 432 111 83 154 146 43 70 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
243 
disease_progression 
H-positive risk:  699 667 81 1037 434 112 1124 427 149 69 155 46 
H-negative risk:  667 699 1124 1037 427 434 112 81 155 149 46 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
244 
disease_progression 
H-positive risk:  698 667 83 1037 434 113 1124 428 146 69 156 45 
H-negative risk:  667 698 1124 1037 428 434 113 83 156 146 45 69 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
245 
disease_progression 
H-positive risk:  704 661 85 1033 432 115 1119 436 148 67 157 43 
H-negative risk:  661 704 1119 1033 436 432 115 85 157 148 43 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
246 
disease_progression 
H-positive risk:  699 669 84 1026 433 114 1123 434 149 67 159 43 
H-negative risk:  669 699 1123 1026 434 433 114 84 159 149 43 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
247 
disease_progression 
H-positive risk:  693 671 80 1024 437 114 1118 444 151 67 158 43 
H-negative risk:  671 693 1118 1024 444 437 114 80 158 151 43 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
101 new agents 
248 
disease_progression 
H-positive risk:  689 674 83 1026 432 114 1122 439 150 68 156 47 
H-negative risk:  674 689 1122 1026 439 432 114 83 156 150 47 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
249 
disease_progression 
H-positive risk:  690 675 86 1028 427 112 1116 442 150 69 157 48 
H-negative risk:  675 690 1116 1028 442 427 112 86 157 150 48 69 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
250 
disease_progression 
H-positive risk:  695 668 89 1027 424 113 1116 442 150 68 157 51 
H-negative risk:  668 695 1116 1027 442 424 113 89 157 150 51 68 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
251 
disease_progression 
H-positive risk:  686 666 89 1028 427 107 1124 441 151 69 161 51 
H-negative risk:  666 686 1124 1028 441 427 107 89 161 151 51 69 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
252 
disease_progression 
H-positive risk:  688 673 90 1018 422 105 1116 452 151 70 160 55 
H-negative risk:  673 688 1116 1018 452 422 105 90 160 151 55 70 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
253 
disease_progression 
H-positive risk:  683 678 88 1023 425 103 1117 447 150 73 160 53 
H-negative risk:  678 683 1117 1023 447 425 103 88 160 150 53 73 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
254 
disease_progression 
H-positive risk:  687 675 83 1027 423 101 1111 457 151 73 160 52 
H-negative risk:  675 687 1111 1027 457 423 101 83 160 151 52 73 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
255 
disease_progression 
H-positive risk:  685 682 82 1025 414 101 1116 457 148 75 163 52 
H-negative risk:  682 685 1116 1025 457 414 101 82 163 148 52 75 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
256 
disease_progression 
H-positive risk:  680 685 85 1027 409 101 1119 455 151 75 160 53 
H-negative risk:  685 680 1119 1027 455 409 101 85 160 151 53 75 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
257 
disease_progression 
H-positive risk:  682 679 83 1023 408 100 1117 465 149 76 162 56 
H-negative risk:  679 682 1117 1023 465 408 100 83 162 149 56 76 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
258 
disease_progression 
H-positive risk:  679 690 82 1025 409 98 1109 462 155 74 162 55 
H-negative risk:  690 679 1109 1025 462 409 98 82 162 155 55 74 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
259 
disease_progression 
H-positive risk:  676 688 80 1023 415 103 1111 455 157 72 163 57 
H-negative risk:  688 676 1111 1023 455 415 103 80 163 157 57 72 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
260 
disease_progression 
H-positive risk:  688 691 79 1023 408 102 1111 451 156 72 160 59 
H-negative risk:  691 688 1111 1023 451 408 102 79 160 156 59 72 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
261 
disease_progression 
H-positive risk:  682 690 79 1020 413 104 1115 449 157 73 162 56 
H-negative risk:  690 682 1115 1020 449 413 104 79 162 157 56 73 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
262 
disease_progression 
H-positive risk:  682 698 82 1020 410 104 1117 444 154 73 162 54 
H-negative risk:  698 682 1117 1020 444 410 104 82 162 154 54 73 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
263 
disease_progression 
H-positive risk:  682 702 83 1029 406 106 1110 440 156 71 163 52 
H-negative risk:  702 682 1110 1029 440 406 106 83 163 156 52 71 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
264 
disease_progression 
H-positive risk:  676 699 85 1032 406 106 1110 441 159 72 163 51 
H-negative risk:  699 676 1110 1032 441 406 106 85 163 159 51 72 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
265 
disease_progression 
H-positive risk:  676 695 86 1035 412 104 1109 442 161 71 161 48 
H-negative risk:  695 676 1109 1035 442 412 104 86 161 161 48 71 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
266 
disease_progression 
H-positive risk:  675 695 84 1045 398 105 1116 444 162 69 160 47 
H-negative risk:  695 675 1116 1045 444 398 105 84 160 162 47 69 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
267 
disease_progression 
H-positive risk:  677 693 83 1053 398 106 1113 443 162 67 158 47 
H-negative risk:  693 677 1113 1053 443 398 106 83 158 162 47 67 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 67 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
268 
disease_progression 
H-positive risk:  679 698 83 1056 399 105 1108 442 160 66 155 49 
H-negative risk:  698 679 1108 1056 442 399 105 83 155 160 49 66 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 66 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
269 
disease_progression 
H-positive risk:  681 697 83 1054 403 104 1114 428 163 67 157 49 
H-negative risk:  697 681 1114 1054 428 403 104 83 157 163 49 67 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 67 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
270 
disease_progression 
H-positive risk:  689 698 81 1052 398 102 1115 430 159 69 156 51 
H-negative risk:  698 689 1115 1052 430 398 102 81 156 159 51 69 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
271 
disease_progression 
H-positive risk:  693 694 79 1060 399 98 1122 431 154 66 151 53 
H-negative risk:  694 693 1122 1060 431 399 98 79 151 154 53 66 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
272 
disease_progression 
H-positive risk:  690 696 79 1063 394 100 1121 428 156 68 152 53 
H-negative risk:  696 690 1121 1063 428 394 100 79 152 156 53 68 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
273 
disease_progression 
H-positive risk:  696 687 78 1064 398 101 1114 432 158 69 154 49 
H-negative risk:  687 696 1114 1064 432 398 101 78 154 158 49 69 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
87 new agents 
274 
disease_progression 
H-positive risk:  700 693 79 1059 393 98 1114 426 162 70 157 49 
H-negative risk:  693 700 1114 1059 426 393 98 79 157 162 49 70 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 74 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
275 
disease_progression 
H-positive risk:  698 706 80 1061 395 96 1102 425 159 69 160 49 
H-negative risk:  706 698 1102 1061 425 395 96 80 160 159 49 69 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
276 
disease_progression 
H-positive risk:  695 703 81 1054 396 94 1102 432 165 67 162 49 
H-negative risk:  703 695 1102 1054 432 396 94 81 162 165 49 67 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 71 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
277 
disease_progression 
H-positive risk:  692 703 82 1055 402 93 1102 428 165 65 163 50 
H-negative risk:  703 692 1102 1055 428 402 93 82 163 165 50 65 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
278 
disease_progression 
H-positive risk:  696 700 83 1074 399 93 1088 426 163 67 160 51 
H-negative risk:  700 696 1088 1074 426 399 93 83 160 163 51 67 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 74 14 

clinical_engagement 
diagnosis 
demography 
80 new agents 
279 
disease_progression 
H-positive risk:  701 696 84 1080 400 91 1081 430 165 66 155 51 
H-negative risk:  696 701 1081 1080 430 400 91 84 155 165 51 66 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 74 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
280 
disease_progression 
H-positive risk:  705 699 84 1080 400 93 1073 433 163 64 155 51 
H-negative risk:  699 705 1073 1080 433 400 93 84 155 163 51 64 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
281 
disease_progression 
H-positive risk:  699 705 81 1073 409 96 1064 438 159 67 159 50 
H-negative risk:  705 699 1064 1073 438 409 96 81 159 159 50 67 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
282 
disease_progression 
H-positive risk:  699 705 82 1072 410 97 1069 434 157 65 160 50 
H-negative risk:  705 699 1069 1072 434 410 97 82 160 157 50 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 76 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
283 
disease_progression 
H-positive risk:  693 706 83 1079 406 98 1068 433 164 64 160 46 
H-negative risk:  706 693 1068 1079 433 406 98 83 160 164 46 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 74 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
284 
disease_progression 
H-positive risk:  685 712 80 1085 401 98 1075 432 166 64 157 45 
H-negative risk:  712 685 1075 1085 432 401 98 80 157 166 45 64 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
92 new agents 
285 
disease_progression 
H-positive risk:  693 718 81 1096 400 99 1063 422 164 63 155 46 
H-negative risk:  718 693 1063 1096 422 400 99 81 155 164 46 63 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 73 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
286 
disease_progression 
H-positive risk:  698 709 83 1103 404 98 1065 421 162 58 153 46 
H-negative risk:  709 698 1065 1103 421 404 98 83 153 162 46 58 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
84 new agents 
287 
disease_progression 
H-positive risk:  698 713 84 1098 397 100 1066 424 165 55 153 47 
H-negative risk:  713 698 1066 1098 424 397 100 84 153 165 47 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 73 12 

clinical_engagement 
diagnosis 
demography 
91 new agents 
288 
disease_progression 
H-positive risk:  686 717 81 1099 400 101 1071 424 162 54 154 51 
H-negative risk:  717 686 1071 1099 424 400 101 81 154 162 51 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 73 12 

clinical_engagement 
diagnosis 
demography 
78 new agents 
289 
disease_progression 
H-positive risk:  685 713 81 1097 399 102 1088 415 163 55 152 50 
H-negative risk:  713 685 1088 1097 415 399 102 81 152 163 50 55 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 70 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
290 
disease_progression 
H-positive risk:  681 711 84 1100 397 104 1089 417 164 54 150 49 
H-negative risk:  711 681 1089 1100 417 397 104 84 150 164 49 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 73 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
291 
disease_progression 
H-positive risk:  673 717 84 1091 400 104 1104 413 162 55 149 48 
H-negative risk:  717 673 1104 1091 413 400 104 84 149 162 48 55 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 75 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
292 
disease_progression 
H-positive risk:  671 715 87 1094 408 104 1099 412 163 55 143 49 
H-negative risk:  715 671 1099 1094 412 408 104 87 143 163 49 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
78 new agents 
293 
disease_progression 
H-positive risk:  679 712 86 1102 405 104 1089 409 165 54 144 51 
H-negative risk:  712 679 1089 1102 409 405 104 86 144 165 51 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
294 
disease_progression 
H-positive risk:  682 713 86 1095 405 101 1095 410 167 55 140 51 
H-negative risk:  713 682 1095 1095 410 405 101 86 140 167 51 55 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 74 13 

clinical_engagement 
diagnosis 
demography 
82 new agents 
295 
disease_progression 
H-positive risk:  689 714 88 1094 402 97 1091 407 173 55 138 52 
H-negative risk:  714 689 1091 1094 407 402 97 88 138 173 52 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
296 
disease_progression 
H-positive risk:  689 711 86 1102 393 100 1090 413 169 57 139 51 
H-negative risk:  711 689 1090 1102 413 393 100 86 139 169 51 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
297 
disease_progression 
H-positive risk:  683 712 85 1088 398 103 1094 420 171 52 144 50 
H-negative risk:  712 683 1094 1088 420 398 103 85 144 171 50 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 71 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
298 
disease_progression 
H-positive risk:  670 713 83 1083 396 106 1103 425 172 53 145 51 
H-negative risk:  713 670 1103 1083 425 396 106 83 145 172 51 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
60 new agents 
299 
disease_progression 
H-positive risk:  662 715 82 1091 397 104 1112 419 172 52 143 51 
H-negative risk:  715 662 1112 1091 419 397 104 82 143 172 51 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
85 new agents 
300 
disease_progression 
H-positive risk:  675 715 81 1092 397 106 1102 414 172 50 145 51 
H-negative risk:  715 675 1102 1092 414 397 106 81 145 172 51 50 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 69 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
301 
disease_progression 
H-positive risk:  673 710 84 1093 397 105 1109 407 173 54 141 54 
H-negative risk:  710 673 1109 1093 407 397 105 84 141 173 54 54 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
81 new agents 
302 
disease_progression 
H-positive risk:  671 711 85 1100 394 101 1112 401 174 55 141 55 
H-negative risk:  711 671 1112 1100 401 394 101 85 141 174 55 55 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 71 12 

clinical_engagement 
diagnosis 
demography 
86 new agents 
303 
disease_progression 
H-positive risk:  672 712 84 1090 401 101 1114 399 173 53 144 57 
H-negative risk:  712 672 1114 1090 399 401 101 84 144 173 57 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
304 
disease_progression 
H-positive risk:  675 706 85 1093 404 100 1115 394 171 55 144 58 
H-negative risk:  706 675 1115 1093 394 404 100 85 144 171 58 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
305 
disease_progression 
H-positive risk:  677 699 84 1095 397 97 1116 398 178 55 144 60 
H-negative risk:  699 677 1116 1095 398 397 97 84 144 178 60 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
306 
disease_progression 
H-positive risk:  676 701 84 1094 396 98 1122 395 174 59 143 58 
H-negative risk:  701 676 1122 1094 395 396 98 84 143 174 58 59 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 68 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
307 
disease_progression 
H-positive risk:  671 707 83 1092 389 102 1121 400 173 63 143 56 
H-negative risk:  707 671 1121 1092 400 389 102 83 143 173 56 63 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
308 
disease_progression 
H-positive risk:  679 709 82 1093 382 100 1125 396 175 61 141 57 
H-negative risk:  709 679 1125 1093 396 382 100 82 141 175 57 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
309 
disease_progression 
H-positive risk:  675 710 82 1090 383 98 1134 393 177 61 138 59 
H-negative risk:  710 675 1134 1090 393 383 98 82 138 177 59 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
310 
disease_progression 
H-positive risk:  668 704 80 1095 388 101 1132 389 179 62 142 60 
H-negative risk:  704 668 1132 1095 389 388 101 80 142 179 60 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
311 
disease_progression 
H-positive risk:  666 702 83 1090 392 100 1130 390 181 63 142 61 
H-negative risk:  702 666 1130 1090 390 392 100 83 142 181 61 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
312 
disease_progression 
H-positive risk:  670 697 85 1104 387 98 1123 390 181 66 137 62 
H-negative risk:  697 670 1123 1104 390 387 98 85 137 181 62 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
313 
disease_progression 
H-positive risk:  674 696 85 1109 390 100 1116 386 177 66 136 65 
H-negative risk:  696 674 1116 1109 386 390 100 85 136 177 65 66 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
314 
disease_progression 
H-positive risk:  668 695 86 1113 385 101 1115 390 173 70 139 65 
H-negative risk:  695 668 1115 1113 390 385 101 86 139 173 65 70 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
315 
disease_progression 
H-positive risk:  670 695 85 1113 385 105 1112 385 175 70 139 66 
H-negative risk:  695 670 1112 1113 385 385 105 85 139 175 66 70 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
316 
disease_progression 
H-positive risk:  670 690 87 1119 385 105 1110 385 172 70 142 65 
H-negative risk:  690 670 1110 1119 385 385 105 87 142 172 65 70 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
317 
disease_progression 
H-positive risk:  674 687 88 1118 393 105 1106 377 172 75 141 64 
H-negative risk:  687 674 1106 1118 377 393 105 88 141 172 64 75 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
318 
disease_progression 
H-positive risk:  673 684 90 1112 397 103 1115 374 172 75 141 64 
H-negative risk:  684 673 1115 1112 374 397 103 90 141 172 64 75 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
319 
disease_progression 
H-positive risk:  671 678 92 1112 394 102 1116 382 171 76 144 62 
H-negative risk:  678 671 1116 1112 382 394 102 92 144 171 62 76 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
320 
disease_progression 
H-positive risk:  670 674 93 1119 394 101 1120 381 168 75 142 63 
H-negative risk:  674 670 1120 1119 381 394 101 93 142 168 63 75 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
321 
disease_progression 
H-positive risk:  666 689 95 1114 396 103 1119 375 167 72 147 57 
H-negative risk:  689 666 1119 1114 375 396 103 95 147 167 57 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
322 
disease_progression 
H-positive risk:  657 691 95 1114 399 105 1118 382 164 70 147 58 
H-negative risk:  691 657 1118 1114 382 399 105 95 147 164 58 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
323 
disease_progression 
H-positive risk:  659 685 95 1113 399 108 1119 389 163 65 149 56 
H-negative risk:  685 659 1119 1113 389 399 108 95 149 163 56 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
324 
disease_progression 
H-positive risk:  662 683 98 1115 406 108 1110 388 161 69 146 54 
H-negative risk:  683 662 1110 1115 388 406 108 98 146 161 54 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
325 
disease_progression 
H-positive risk:  664 684 94 1114 408 109 1106 393 162 67 147 52 
H-negative risk:  684 664 1106 1114 393 408 109 94 147 162 52 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
326 
disease_progression 
H-positive risk:  676 678 92 1110 413 110 1104 396 160 62 146 53 
H-negative risk:  678 676 1104 1110 396 413 110 92 146 160 53 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
327 
disease_progression 
H-positive risk:  674 673 93 1113 415 110 1102 396 162 62 146 54 
H-negative risk:  673 674 1102 1113 396 415 110 93 146 162 54 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
328 
disease_progression 
H-positive risk:  671 664 94 1113 420 109 1106 395 162 65 148 53 
H-negative risk:  664 671 1106 1113 395 420 109 94 148 162 53 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
329 
disease_progression 
H-positive risk:  671 669 95 1110 417 111 1103 395 165 65 145 54 
H-negative risk:  669 671 1103 1110 395 417 111 95 145 165 54 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
330 
disease_progression 
H-positive risk:  664 665 98 1126 418 111 1103 394 165 61 143 52 
H-negative risk:  665 664 1103 1126 394 418 111 98 143 165 52 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
331 
disease_progression 
H-positive risk:  660 669 97 1130 416 112 1100 395 161 62 145 53 
H-negative risk:  669 660 1100 1130 395 416 112 97 145 161 53 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
332 
disease_progression 
H-positive risk:  655 668 96 1127 415 112 1106 394 157 67 149 54 
H-negative risk:  668 655 1106 1127 394 415 112 96 149 157 54 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
333 
disease_progression 
H-positive risk:  656 676 93 1123 416 113 1102 392 156 68 153 52 
H-negative risk:  676 656 1102 1123 392 416 113 93 153 156 52 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
334 
disease_progression 
H-positive risk:  658 679 93 1122 416 112 1105 387 155 68 153 52 
H-negative risk:  679 658 1105 1122 387 416 112 93 153 155 52 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
335 
disease_progression 
H-positive risk:  654 677 92 1128 420 112 1104 385 155 68 152 53 
H-negative risk:  677 654 1104 1128 385 420 112 92 152 155 53 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
90 new agents 
336 
disease_progression 
H-positive risk:  656 674 91 1119 419 113 1113 382 156 70 151 56 
H-negative risk:  674 656 1113 1119 382 419 113 91 151 156 56 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
337 
disease_progression 
H-positive risk:  655 671 91 1115 417 111 1113 388 157 70 155 57 
H-negative risk:  671 655 1113 1115 388 417 111 91 155 157 57 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
338 
disease_progression 
H-positive risk:  652 662 91 1123 414 107 1111 393 161 72 157 57 
H-negative risk:  662 652 1111 1123 393 414 107 91 157 161 57 72 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
339 
disease_progression 
H-positive risk:  657 667 89 1121 415 105 1099 400 160 70 160 57 
H-negative risk:  667 657 1099 1121 400 415 105 89 160 160 57 70 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
340 
disease_progression 
H-positive risk:  663 673 89 1113 412 104 1092 406 160 70 162 56 
H-negative risk:  673 663 1092 1113 406 412 104 89 162 160 56 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
341 
disease_progression 
H-positive risk:  666 674 90 1109 412 102 1090 405 163 69 163 57 
H-negative risk:  674 666 1090 1109 405 412 102 90 163 163 57 69 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
342 
disease_progression 
H-positive risk:  666 675 89 1109 412 101 1087 408 159 71 160 63 
H-negative risk:  675 666 1087 1109 408 412 101 89 160 159 63 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
56 new agents 
343 
disease_progression 
H-positive risk:  663 676 91 1110 415 103 1082 407 157 71 161 64 
H-negative risk:  676 663 1082 1110 407 415 103 91 161 157 64 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
344 
disease_progression 
H-positive risk:  656 676 92 1117 415 103 1077 409 158 71 162 64 
H-negative risk:  676 656 1077 1117 409 415 103 92 162 158 64 71 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
345 
disease_progression 
H-positive risk:  653 672 94 1122 407 102 1080 413 159 69 160 69 
H-negative risk:  672 653 1080 1122 413 407 102 94 160 159 69 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  646 668 95 1114 414 103 1089 419 156 68 161 67 
H-negative risk:  668 646 1089 1114 419 414 103 95 161 156 67 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
347 
disease_progression 
H-positive risk:  650 672 97 1107 408 108 1090 417 155 67 161 68 
H-negative risk:  672 650 1090 1107 417 408 108 97 161 155 68 67 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
348 
disease_progression 
H-positive risk:  654 671 102 1103 411 109 1094 415 153 67 154 67 
H-negative risk:  671 654 1094 1103 415 411 109 102 154 153 67 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
349 
disease_progression 
H-positive risk:  653 671 102 1092 418 113 1091 424 154 65 153 64 
H-negative risk:  671 653 1091 1092 424 418 113 102 153 154 64 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
350 
disease_progression 
H-positive risk:  651 671 99 1101 416 112 1093 425 152 66 150 64 
H-negative risk:  671 651 1093 1101 425 416 112 99 150 152 64 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
351 
disease_progression 
H-positive risk:  653 668 100 1103 412 114 1095 421 151 68 151 64 
H-negative risk:  668 653 1095 1103 421 412 114 100 151 151 64 68 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
352 
disease_progression 
H-positive risk:  646 668 97 1101 410 116 1096 429 153 68 153 63 
H-negative risk:  668 646 1096 1101 429 410 116 97 153 153 63 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
353 
disease_progression 
H-positive risk:  645 662 102 1107 409 116 1097 424 154 67 154 63 
H-negative risk:  662 645 1097 1107 424 409 116 102 154 154 63 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
354 
disease_progression 
H-positive risk:  640 666 101 1100 408 120 1106 424 154 68 150 63 
H-negative risk:  666 640 1106 1100 424 408 120 101 150 154 63 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
355 
disease_progression 
H-positive risk:  637 665 100 1110 407 118 1112 420 154 68 146 63 
H-negative risk:  665 637 1112 1110 420 407 118 100 146 154 63 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
356 
disease_progression 
H-positive risk:  636 666 100 1107 411 117 1104 428 155 70 146 60 
H-negative risk:  666 636 1104 1107 428 411 117 100 146 155 60 70 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
357 
disease_progression 
H-positive risk:  635 662 99 1121 398 117 1108 427 155 69 146 63 
H-negative risk:  662 635 1108 1121 427 398 117 99 146 155 63 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
358 
disease_progression 
H-positive risk:  644 661 99 1129 396 118 1088 431 157 68 147 62 
H-negative risk:  661 644 1088 1129 431 396 118 99 147 157 62 68 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
359 
disease_progression 
H-positive risk:  650 667 99 1130 398 119 1080 428 160 66 145 58 
H-negative risk:  667 650 1080 1130 428 398 119 99 145 160 58 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
360 
disease_progression 
H-positive risk:  644 666 100 1123 404 118 1075 438 157 70 148 57 
H-negative risk:  666 644 1075 1123 438 404 118 100 148 157 57 70 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
Time difference of 15.94731 mins
This is task 28
date
